ATLANTA—Rapid diagnostic tests for malaria promise to distinguish accurately — and at low cost — patients with fever caused by malaria so that the only patients to receive antimalarial treatment are the ones who truly have the disease. That’s according to the findings of a symposium held to discuss the use of rapid diagnostic tests and artemisinin-based combination therapy (ACT) at the American Society of Tropical Medicine and Hygiene annual meeting held in Atlanta. Two Principal Investigators and the Director of the ACT Consortium — coordinated from the London School of Hygiene and Tropical Medicine — were among those taking part: Dr Hugh Reyburn who works in Tanzania, Dr Toby Leslie based in Afghanistan, and Professor David Schellenberg from London who chaired the discussions. They discuss their findings about the current perceptions and actual use of malaria diagnostics and ACTs in countries where the disease is endemic.
You may also like...
- Previous story On Line ‘Flu Survey Gives Protection Against Future Pandemics
- Next story Healthy Diets In Rich Countries: Benefits, But Also Losses In Poorer Countries
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014